circDLC1, a downstream target of KIAA1429, is a promising prognostic marker for HCC patients, and the circDLC1-HuR-MMP1 axis may serve as a potential therapeutic target for HCC treatment.
Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR.